Ildong Pharmaceutical Co., Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Ildong Pharmaceutical Co., Ltd.
The Pink Sheet’s roundup of key regulatory issues in Korea for 2022 and outlook for this year.
Scrip takes a look at key recent drug development activities in the NASH area by Korean firms, which are now pursuing the global development of their candidates as they look to leverage innovation to expand internationally.
The recent World Bio Summit in Seoul saw executives of global pharmas including Pfizer, Merck and Moderna discuss strategic approaches to advance the development of, and ensure equitable access to, vaccines, and also highlighted Korea’s potential role in ongoing global efforts.
In Vivo takes an infographic look at where South Korea stands in the development of a wide-ranging set of drugs for Alzheimer’s disease and which companies are still in the challenging race.
- Medical Devices
- Generic Drugs
- OTC, Consumer
- Consumables, Central Supplies
- Implantable Devices
- Infection Control-Sterilization
- Infusion Therapy Equipment and Supplies
- Monitoring Equipment & Devices
- Radiofrequency Devices
- Rehabilitation Equipment and Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
Drug Discovery Tools
- Natural Products
- Molecular Diversity
- Drug Discovery Tools
- Other Names / Subsidiaries
- Idience Co., Ltd.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.